A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
University of Regensburg
Stanford University
Duke University
Duke University
National Cancer Institute (NCI)
Duke University
Duke University